BPH overview
GSK's commitment to research in urology and benign prostatic hyperplasia (BPH) has helped to improve the lives of patients throughout the world, with more than 20 years’ experience of aiding patients and physicians in the management of this disease.
Duodart
dutasteride/tamsulosin
Find out about our products in the Urology portfolio, including prescribing and safety information.
Trade marks are owned by or licensed to the GSK group of companies.
©2021 GSK group of companies or its licensor.